Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BMS' Purchase Of Amira: When An Acquisition Is Really An Asset Sale

Sep 01 2011

Related Content

BMS Bets On Amira's IPF Drug In $325M Acquisition

Jul 22 2011

Forma To Play To Its Strengths WIth Genentech Deal

Jul 01 2011

PanGenetics' NGF Antibody Sale Illustrates Index's Asset-Focused Strategy

Dec 01 2009

Atlas, CMEA Test New Biotech Model

Apr 01 2011

Doubling Its Bet In IPF, Gilead Buys Arresto Biosciences For $225 Million

Dec 20 2010

After Complex Sale, Amira Scientist And VC Team Up Again For Discovery Start-up

Jul 27 2011

Related Companies

Bristol Myers Squibb Company

GSK plc

Gilead Sciences, Inc.

Sirion Holdings, Inc.

Novartis AG

Bausch Health Companies Inc.

Abbott

PanGenetics B.V.

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window